InvestorsHub Logo
Followers 16
Posts 1374
Boards Moderated 0
Alias Born 07/27/2015

Re: frrol post# 333875

Wednesday, 10/27/2021 6:15:34 PM

Wednesday, October 27, 2021 6:15:34 PM

Post# of 470183
That may hold true to BIIB recently approved drug for AD. Heck, it can’t even beat the soc without serious side effects.

Blarcamesine just may be the new SOC for AD, PD, Rett, and probably many others in the next 2-3 years.

Let THAT possibility sink in……..



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News